key: cord-0993560-cvzwj7v9
authors: Bertoldi, Giovanni; Gianesello, Lisa; Calò, Lorenzo A.
title: Letter: ACE2, Rho kinase inhibition and the potential role of vitamin D against COVID‐19
date: 2020-07-13
journal: Aliment Pharmacol Ther
DOI: 10.1111/apt.15895
sha: 5b31eb45fdd02fdc7c95a1e349dd432901a055b2
doc_id: 993560
cord_uid: cvzwj7v9

LINKED CONTENT This article is linked to Panarese et al and Kumar et al papers. To view these articles, visit https://doi.org/10.1111/apt.15752 and https://doi.org/10.1111/apt.15801.

The known immunomodulatory roles of vitamin D including the down-regulation of pro-inflammatory cytokines, in particular via its inhibitory effects on the activation of the renin-angiotensin system 

Letter: covid-19, and vitamin D

Counter-regulatory renin-angiotensin system in cardiovascular disease

Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19

Letter: does vitamin D have a potential role against COVID-19?

Vitamin D attenuates myocardial ischemia-reperfusion injury by inhibiting inflammation via suppressing the RhoA/ROCK/NF-ĸB pathway

Plausibility of therapeutic effects of Rho kinase inhibitors against severe acute respiratory syndrome coronavirus 2 (COVID-19)

Understanding the mechanisms of angiotensin II signaling involved in hypertension and its longterm sequelae: insights from Bartter's and Gitelman's syndromes, human models of endogenous angiotensin II signaling antagonism

RhoA/Rho kinase) in cardiovascular-renal pathophysiology: a review of new advancements

ACE2 and angiotensin 1-7 are increased in a human model of cardiovascular hyporeactivity: pathophysiological implications

Rho kinase inhibitors for SARS-CoV-2 induced acute respiratory distress syndrome: support from Bartter's and Gitelman's syndrome patients